Camber Capital Management LP
Q2 2025 13F Holdings
- Locationboston, MA
- Num holdings
25
- Value ($000)
$1,065,229
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001444043
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $308.93 M | 29 % | 500,000 | put | |
ZBH ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | $91.21 M | 9 % | 1,000,000 | ||
BAX BAXTER INTL INC | COM | 071813109 | $86.30 M | 8 % | 2,850,000 | ||
HUM HUMANA INC | COM | 444859102 | $73.34 M | 7 % | 300,000 | ||
CVS CVS HEALTH CORP | COM | 126650100 | $72.43 M | 7 % | 1,050,000 | ||
GMED GLOBUS MED INC | CL A | 379577208 | $47.22 M | 4 % | 800,000 | ||
ICLR ICON PLC | SHS | G4705A100 | $43.63 M | 4 % | 300,000 | ||
ASND ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | $43.15 M | 4 % | 250,000 | ||
MRK MERCK & CO INC | COM | 58933Y105 | $39.58 M | 4 % | 500,000 | ||
GSK GSK PLC | SPONSORED ADR | 37733W204 | $38.40 M | 4 % | 1,000,000 | call |
Rows Per Page
10
- 10
- 50
- 100